Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3>Reduction in L-type Ca2+ current (ICa,L) density is a hallmark of the electrical remodeling in atrial fibrillation (AF). The expression of miR-155, whose predicted target gene is the α1c subunit of the calcium channel (CACNA1C), was upregulated in atrial cardiomyocytes (aCMs) from patients with paroxysmal AF.The study is to determine miR-155 could target the gene expression of ICa,L and contribute to electrical remodeling in AF.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3>The expression of miR-155 and CACNA1C was assessed in aCMs from patients with paroxysmal AF and healthy control. ICa,L properties were observed after miR-155 transfection in human induced pluripotent stem cell derived atrial cardiomyocytes (hiPSC-aCMs). Furthermore, an miR-155 transgene (Tg) and knock-out (KO) mouse model was generated to determine whether miR-155 was involved in ICa,L-related electrical remodeling in AF by targeting CACNA1C.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3>The expression level of miR-155 was increased, while the expression level of CACNA1C reduced in the aCMs of patients with AF. miR-155 transfection in hiPSC-aCMs produced changes in ICa,L properties qualitatively similar to those produced by AF. miR-155/Tg mice developed a shortened action potential duration and increased vulnerability to AF, which was associated with decreased ICa,L and attenuated by an miR-155 inhibitor. Finally, the genetic inhibition of miR-155 prevented AF induction in miR-155/KO mice with no changes in ICa,L properties.<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3>The increased miR-155 expression in aCMs was sufficient for the reduction in the density of ICa,L and the underlying electronic remodeling. The inhibition of miR-155 prevented ICa,L-related electric remodeling in AF and might constitute a novel anti-AF approach targeting electrical remodeling.

Microrna Associated with Generation, Development, and Maintenance of Atrial Fibrillation

Integrated Analysis of the microRNA–mRNA Network Predicts Potential Regulators of Atrial Fibrillation in Humans

Identification of microRNA-mRNA interactions in atrial fibrillation using microarray expression profiles and bioinformatics analysis

Identification of miR-1 and miR-499 in chronic atrial fibrillation by bioinformatics analysis and experimental validation

The Integrative Regulatory Network Of Circrna, Microrna, And Mrna In Atrial Fibrillation

microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation

Integrated Analysis of circRNA-miRNA-mRNA-Mediated Network and Its Potential Function in Atrial Fibrillation

Identification of Pivotal MicroRNAs and Target Genes Associated with Persistent Atrial Fibrillation Based on Bioinformatics Analysis

Identification of Circrna-Mirna-mrna Regulatory Network and Autophagy Interaction Network in Atrial Fibrillation Based on Bioinformatics Analysis

Unveiling Clinical Biomarkers and Therapeutic Avenues in Atrial Fibrillation and Associated Stroke—A Systematic Review

Micrornas in Cardiovascular Development

Dysregulated Expression of Micrornas and Mrnas in Myocardial Infarction.

Circulating Microrna-1A is a Biomarker of Graves' Disease Patients with Atrial Fibrillation.

Distinct microRNA expression signatures in human right atrial and ventricular myocardium

Regulation of Cardiovascular Development, Function and Hypertension by Micrornas

Abstract 15963: Microrna Biophysically Modulates Cardiac Physiology Via Directly Binding to Ion Channel

Small non‐coding RNA signatures in atrial appendages of patients with atrial fibrillation

Inhibiting microRNA-155 attenuates atrial fibrillation by targeting CACNA1C

Avoiding Heparin Inhibition in Circulating MicroRNAs Amplification.

MicroRNAs and therapeutic potentials in acute and chronic cardiac disease

Role of microRNA in cardiovascular pathophysiology